BioCentury
ARTICLE | Clinical News

Tetrodin: Began Phase Ib/Ic testing

April 9, 2001 7:00 AM UTC

International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodiu...